Michael C. Greiner - 06 Mar 2023 Form 4/A - Amendment Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role: SVP - Chief Financial Officer
Signature: /s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol: AVNS
Transactions as of: 06 Mar 2023
Net transactions value: -$89,956
Form type: 4/A - Amendment
Filing time: 23 Mar 2023, 11:31:04 UTC
Date Of Original Report: 07 Mar 2023
Previous filing: 04 Jan 2023
Next filing: 09 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVNS	Common Stock	Award	$0	+34,619	+37%	$0.000000	129,050	06 Mar 2023	Direct	F1, F2
transaction	AVNS	Common Stock	Tax liability	$89,956	-3,037	-2.4%	$29.62	126,013	06 Mar 2023	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.
F2	Total beneficially owned includes 339 shares acquired on December 30, 2022 and 327 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan.
F3	Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.

Remarks:

This Form 4/A is being filed to correct an error in the calculation of the number of time-based restricted share units issued to the Reporting Person on March 6, 2023 pursuant to the Issuer's 2021 Long Term Incentive Plan.